GSK gets Japan approval for prefilled Shingrix vaccine
(Alliance News) - GSK PLC on Thursday said its Shingrix shingles vaccine has been approved by Japan's Ministry of Health, Labour & Welfare. Read More
| Price | 1,780.00p on 11-09-2026 at 07:40:14 |
|---|---|
| Change | 4.50p 0.25% |
| Buy | 1,780.50p |
| Sell | 1,779.50p |
| Last Trade: | Sell 7.00 at 1,779.50p |
| Day's Volume: | 259,964 |
| Last Close: | 1,775.50p |
| Open: | 1,786.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,772.50p - 1,793.00p |
| 52wk Range: | 1,455.00p - 2,282.00p |
| Market Capitalisation: | £71.32b |
| VWAP: | 1,778.66993p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 7 | 1,779.50p | SI Trade |
08:40:13 - 11-Sep-26 |
| Sell* | 12 | 1,779.50p | Ordinary |
08:39:59 - 11-Sep-26 |
| Unknown* | 4 | 1,783.48325p | SI Trade Currency Conversion |
08:39:40 - 11-Sep-26 |
| Buy* | 50 | 1,780.00p | Automatic Execution |
08:39:40 - 11-Sep-26 |
| Sell* | 174 | 1,779.50p | Automatic Execution |
08:39:40 - 11-Sep-26 |
| Sell* | 391 | 1,779.50p | Automatic Execution |
08:39:40 - 11-Sep-26 |
| Sell* | 181 | 1,779.50p | Automatic Execution |
08:39:40 - 11-Sep-26 |
| Sell* | 107 | 1,779.50p | Automatic Execution |
08:39:40 - 11-Sep-26 |
| Sell* | 286 | 1,779.50p | Automatic Execution |
08:39:40 - 11-Sep-26 |
| Sell* | 380 | 1,779.50p | Automatic Execution |
08:39:40 - 11-Sep-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 10th Sep 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 10th Sep 2026 7:00 am | RNS | Japan approval of Shingrix in a prefilled syringe |
| 9th Sep 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 9th Sep 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 1st Sep 2026 3:00 pm | RNS | Total Voting Rights |
| 1st Sep 2026 7:00 am | RNS | mRNA flu vaccine candidate to advance to phase III |
| 26th Aug 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 24th Aug 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 24th Aug 2026 7:02 am | RNS | First global approval for Hibsago in Japan |
| 24th Aug 2026 7:00 am | RNS | US FDA to review Jemperli for rectal cancer |